Improved arthropathy scores after use of Extended Half-Life (EHL) products in prophylactic treatment of adult patients with Haemophilia A & B

被引：0
|
作者：
Christidi, Styliani-Despoina [1 ]
Thevaeos, George [1 ]
Zannou, Anna [2 ,3 ]
Vlahopoulou, Dimitra [2 ,3 ]
Veziris, George [1 ]
Gavalaki, Maria [2 ,3 ]
Kourampa, Anna [2 ,3 ]
机构：
[1] Laikon Gen Hosp, Dept Orthoped, Athens, Greece
[2] Blood Transfus Ctr, Athens, Greece
[3] Natl Reference Ctr Congenital Bleeding Disorders, Athens, Greece
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
Haemophilia; Extended Half-Life (EHL); HJHS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-040
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [41] Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US
    Chhabra, Amit
    Alvir, Jose
    Spurden, Dean
    Fogarty, Patrick F.
    Tortella, Bartholomew
    McDonald, Margaret
    Pleil, Andreas M.
    BLOOD, 2017, 130
  • [42] USE OF EXTENDED HALF-LIFE FACTOR IX PRODUCTS IN REPRESENTATIVE PAEDIATRIC PATIENTS WITH SEVERE FACTOR IX DEFICIENCY
    Wu, John K.
    Chan, Anthony K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E96 - E96
  • [43] Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products
    Megias-Vericat, J. E.
    Bonanad Boix, S.
    Berrueco Moreno, R.
    Mingot-Castellano, M. E.
    Rodriguez Lopez, M.
    Canaro Hirnyk, M.
    Mateo Arranz, J.
    Calvo Villas, J. M.
    Haya Guaita, S.
    Mesegue Meda, M.
    Lopez Jaime, F.
    Albo-Lopez, C.
    Palomero-Massanet, A.
    Vilalta Seto, N.
    Larrode Lecinena, I
    Cid Haro, A. R.
    Poveda Andres, J. L.
    THROMBOSIS RESEARCH, 2022, 216 : 35 - 42
  • [44] JOINT STATUS FOLLOW-UP IN HAEMOPHILIA PATIENTS ON PROPHYLAXIS WITH EXTENDED HALF LIFE (EHL) FACTORS USING THE HAEMOPHILIA EARLY ARTHROPATHY DETECTION WITH ULTRASOUND (HEAD-US) SCORE: A SINGLE CENTRE EXPERIENCE
    Ceglie, T.
    Pollio, B.
    Messina, M.
    Martinoli, C.
    Pagliarino, M.
    Ricca, I.
    HAEMOPHILIA, 2020, 26 : 60 - 60
  • [45] Paediatric cases of previously untreated patients with severe haemophilia A and B on extended half life products: A single centre experience
    Dettoraki, A.
    Michalopoulou, A.
    Papageorgiou, N.
    Saslis, S.
    Stamati, I.
    Thymianou, S.
    Kapsimali, Z.
    Pergantou, H.
    HAEMOPHILIA, 2024, 30 : 61 - 61
  • [46] CLINICAL APPLICATION OF EXTENDED HALF-LIFE PRODUCT ALBUTREPENONACOG ALFA (RIX-FP) IN CHILDREN WITH HAEMOPHILIA B
    Detatoraki, A.
    Michalopoulou, A.
    Mazarakis, M.
    Saslis, S.
    Pappa, M.
    Iliaki, M.
    Thymianou, S.
    Kapsimali, Z.
    Pergantou, H.
    HAEMOPHILIA, 2023, 29 : 66 - 66
  • [47] FVIII dosages in persons with haemophilia A treated with extended half-life products: From local biology to optimized patient management
    Perrier-Cornet, Andreas
    Philippe, Aurelien
    Lambert, Thierry
    d'Oiron, Roseline
    Rafowicz, Anne
    Lavenu-Bombled, Cecile
    Combe, Sophie
    Gillibert, Andre
    Proulle, Valerie
    HAEMOPHILIA, 2019, 25 (06) : E361 - E363
  • [48] Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients' Perspective
    Roggeri, Daniela Paola
    Zanon, Ezio
    Biasoli, Chiara
    Roggeri, Alessandro
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2020, 21 (01) : 59 - 68
  • [49] Improvement in health status and quality of life in patients with haemophilia B treated with nonacog beta pegol, an extended half-life glycopegylated recombinant FIX product
    Kearney, Susan
    Meunier, Juliette
    Hoxer, Christina S.
    Yee, Donald L.
    HAEMOPHILIA, 2016, 22 : 119 - 119
  • [50] Real-World expenditures associated with Prophylactic Factor IX replacement in Severe Hemophilia B patients in the US: A comparison between standard and extended half-life products
    Fogarty, Patrick
    Alvir, Jose
    Spurden, Dean
    Tortella, Bartholomew
    McDonald, Margaret
    Pleil, Andreas
    Chhabra, Amit
    HAEMOPHILIA, 2018, 24 : 26 - 26
12345